Crowdsourcing for university community engagement COVID-19 safety strategies

What The Study Did: Researchers evaluated the compliance of hospitals with a Centers for Medicare & Medicaid Services ruling mandating that a list of charges for services, procedures and items be publicly available and in a machine-readable file. Authors: David Hsiehchen, M.D., of the University of Texas Southwestern Medical Center in Dallas, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.10109) Editor's Note: Please see the article for additional information, ...

Tokyo, Japan - Oxygen is crucial to many forms of life. Its delivery to the organs and tissues of the body through the process of respiration is vital for most biological processes. Now, researchers at Tokyo Medical and Dental University (TMDU) have shown that oxygen can be delivered through the wall of the intestine to compensate for the reduced availability of oxygen within the body that occurs in lung diseases that cause respiratory failure. To breathe is to live; for higher animals, respiration involves absorbing oxygen and excreting carbon dioxide at gills or in the lungs. However, some animals have evolved alternative ventilatory mechanisms: loaches, catfish, sea cucumbers and orb-weaving spiders can absorb oxygen through their hindgut to ...

Scientists have uncovered the exact mechanism that causes new solar cells to break down, and suggest a potential solution. Solar cells harness energy from the Sun and provide an alternative to non-renewable energy sources like fossil fuels. However, they face challenges from costly manufacturing processes and poor efficiency - the amount of sunlight converted to useable energy. Perovskites are materials developed for next-generation solar cells. Although perovskites are more flexible cheaper to make than traditional silicon-based solar panels and deliver similar efficiency, perovskites ...

University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin. The researchers believe by inhibiting the receptor, they may be able to eliminate toxic side-effects from the drug that cause the hearing loss. Cisplatin is an incredibly effective chemotherapeutic when it comes to treating solid tumours in children, contributing to an 80 per cent overall survival rate over five years, according to U of A researcher Amit Bhavsar, an assistant professor in the Department of Medical Microbiology & Immunology. The problem ...

Boston - While overall emergency department visits have decreased during the pandemic, nonfatal opioid overdose visits have more than doubled. However, few patients who overdosed on opioids had received a prescription for naloxone, a medication designed to block the effects of opioids on the brain and rapidly reverse opioid overdose. In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions. The team's findings, published in the journal JAMA Health Forum, suggest patents with opioid misuse disorders may be experiencing a dangerous decrease in access to the overdose-reversing ...

A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight tumors. The research could improve cancer therapies in the future for millions of people worldwide. The research is published in Nature Communications, a peer-reviewed, open access, scientific journal published by Nature Research. Instead of using chemicals or radiation, immunotherapy is a type of cancer treatment that helps the patient's immune system fight cancer. T cells are a type of white ...

KINGSTON, R.I. - May 14, 2021 - We are frequently reminded of how vulnerable our health and safety are to threats from nature or those who wish to harm us. New sensors developed by Professor Otto Gregory, of the College of Engineering at the University of Rhode Island, and chemical engineering doctoral student Peter Ricci, are so powerful that they can detect threats at the molecular level, whether it's explosive materials, particles from a potentially deadly virus or illegal drugs entering the country. "This is potentially life-saving technology," said Gregory. "We have detected ...

Researchers from Mosquito Alert (who belong to CEAB-CSIC, CREAF and UPF) together with researchers from the University of Budapest have shown that an artificial intelligence algorithm is capable of recognizing the tiger mosquito (Aedes albopictus) in the photos sent by Mosquito Alert users. The results of the study published in Scientific Reports have been obtained by applying deep learning technology or deep learning, an aspect of artificial intelligence that seeks to emulate the way of learning of humans and that has previously been used in the health field to interpret ...

Of the over 400 climate scenarios assessed in the 1.5°C report by the Intergovernmental Panel on Climate Change (IPCC), only around 50 scenarios avoid significantly overshooting 1.5°C. Of those only around 20 make realistic assumptions on mitigation options, for instance the rate and scale of carbon removal from the atmosphere or extent of tree planting, a new study shows. All 20 scenarios need to pull at least one mitigation lever at "challenging" rather than "reasonable" levels, according to the analysis. Hence the world faces a high degree of risk of overstepping the 1.5°C limit. The realistic window for meeting the 1.5°C target is very rapidly closing. If all climate mitigation levers are pulled, it may still be possible ...

The protein made by the ASH1L gene plays a key role in the development of acute leukemia, along with other diseases. The ASH1L protein, however, has been challenging to target therapeutically. Now a team of researchers led by Jolanta Grembecka, Ph.D., and Tomasz Cierpicki, Ph.D., from the University of Michigan has developed first-in-class small molecules to inhibit ASH1L's SET domain -- preventing critical molecular interactions in the development and progression of leukemia. The team's findings, which used fragment-based screening, followed by medicinal chemistry and a structure-based design, appear in Nature Communications. In mouse models of mixed lineage leukemia, the lead compound, known as AS-99, successfully reduced leukemia progression. "This ...